The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
02/21/2023 | Angus Stewart | 6 min read
Can digital tools help cell and gene therapy evolve?
02/16/2023 | Stephanie Sutton
Check out our video interview covering decentralized manufacturing and more.
02/14/2023 | Eric Rhodes | 4 min read
Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.
02/01/2023
Download our free eBook to see what trends and innovations are shaping the industry’s future
01/26/2023 | Kim You-lim | 6 min read
How a streamlined CLD process can fast-track biologics to IND
01/24/2023 | Angus Stewart | 6 min read
New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.
01/09/2023 | Angus Stewart | 4 min read
What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?
12/28/2022 | Naiara Tejados, PhD | 5 min read
Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies
12/27/2022 | Brian Mullan | 12 min read
Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.
12/23/2022 | Rob Coker | 4 min read
Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse